Ricky Edmondson
Concepts (401)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 20 | 2025 | 332 | 1.900 |
Why?
| | Proteome | 13 | 2024 | 175 | 0.990 |
Why?
| | Glomerulonephritis, Membranous | 5 | 2023 | 28 | 0.860 |
Why?
| | Histones | 7 | 2025 | 315 | 0.830 |
Why?
| | Chromatin | 8 | 2025 | 143 | 0.640 |
Why?
| | Saccharomyces cerevisiae Proteins | 8 | 2019 | 132 | 0.640 |
Why?
| | Acute Kidney Injury | 2 | 2025 | 389 | 0.570 |
Why?
| | Saccharomyces cerevisiae | 8 | 2019 | 168 | 0.500 |
Why?
| | Staphylococcus aureus | 4 | 2025 | 312 | 0.490 |
Why?
| | Bacterial Proteins | 7 | 2019 | 347 | 0.490 |
Why?
| | Computational Biology | 3 | 2020 | 209 | 0.480 |
Why?
| | DNA Replication | 5 | 2025 | 159 | 0.460 |
Why?
| | Chromosomal Proteins, Non-Histone | 4 | 2021 | 36 | 0.460 |
Why?
| | Nuclear Pore Complex Proteins | 3 | 2025 | 10 | 0.450 |
Why?
| | DNA-Binding Proteins | 6 | 2021 | 423 | 0.430 |
Why?
| | Phosphoproteins | 3 | 2020 | 123 | 0.400 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2023 | 141 | 0.400 |
Why?
| | Sepsis | 2 | 2025 | 236 | 0.380 |
Why?
| | Lupus Nephritis | 2 | 2023 | 18 | 0.360 |
Why?
| | Database Management Systems | 1 | 2011 | 27 | 0.360 |
Why?
| | Animals | 27 | 2025 | 13485 | 0.350 |
Why?
| | Mice | 21 | 2025 | 5899 | 0.350 |
Why?
| | Cell Cycle Proteins | 5 | 2021 | 168 | 0.350 |
Why?
| | Genomics | 3 | 2011 | 266 | 0.340 |
Why?
| | Mycobacterium | 5 | 2008 | 28 | 0.320 |
Why?
| | Transcription Factors | 6 | 2025 | 570 | 0.310 |
Why?
| | Oncogene Proteins, Fusion | 3 | 2025 | 61 | 0.310 |
Why?
| | Blood Coagulation | 2 | 2025 | 64 | 0.290 |
Why?
| | Tandem Mass Spectrometry | 7 | 2020 | 255 | 0.280 |
Why?
| | Antibodies, Monoclonal | 2 | 2025 | 475 | 0.280 |
Why?
| | Signal Transduction | 5 | 2020 | 1724 | 0.280 |
Why?
| | Melanoma | 2 | 2024 | 272 | 0.270 |
Why?
| | Neoplasms | 3 | 2021 | 1314 | 0.260 |
Why?
| | Lysine | 2 | 2025 | 90 | 0.250 |
Why?
| | Mass Spectrometry | 8 | 2023 | 294 | 0.250 |
Why?
| | Proteolysis | 3 | 2022 | 100 | 0.250 |
Why?
| | Bacillus anthracis | 1 | 2025 | 14 | 0.240 |
Why?
| | Anthrax | 1 | 2025 | 9 | 0.240 |
Why?
| | Humans | 34 | 2025 | 52441 | 0.240 |
Why?
| | Protein Interaction Mapping | 2 | 2020 | 39 | 0.240 |
Why?
| | Factor XI | 1 | 2025 | 4 | 0.240 |
Why?
| | Antigens, Bacterial | 1 | 2025 | 55 | 0.240 |
Why?
| | Gene Silencing | 2 | 2023 | 122 | 0.230 |
Why?
| | Bacterial Toxins | 1 | 2025 | 52 | 0.230 |
Why?
| | Blood Coagulation Disorders | 1 | 2025 | 41 | 0.230 |
Why?
| | Protein Binding | 9 | 2025 | 673 | 0.230 |
Why?
| | Insulin-Like Growth Factor Binding Protein 1 | 1 | 2025 | 16 | 0.230 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2025 | 853 | 0.230 |
Why?
| | Co-Repressor Proteins | 2 | 2023 | 17 | 0.230 |
Why?
| | Homeodomain Proteins | 2 | 2025 | 80 | 0.220 |
Why?
| | Staphylococcal Infections | 2 | 2025 | 270 | 0.220 |
Why?
| | HEK293 Cells | 5 | 2025 | 236 | 0.220 |
Why?
| | Glycine | 1 | 2025 | 78 | 0.220 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2017 | 336 | 0.220 |
Why?
| | Software | 2 | 2020 | 281 | 0.210 |
Why?
| | Phenylalanine | 1 | 2025 | 139 | 0.210 |
Why?
| | Trans-Activators | 2 | 2019 | 137 | 0.210 |
Why?
| | Retroelements | 1 | 2023 | 13 | 0.210 |
Why?
| | Endothelium, Vascular | 1 | 2025 | 263 | 0.210 |
Why?
| | Endogenous Retroviruses | 1 | 2023 | 7 | 0.210 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 230 | 0.210 |
Why?
| | Gammaherpesvirinae | 2 | 2013 | 21 | 0.200 |
Why?
| | Methionine | 1 | 2024 | 142 | 0.190 |
Why?
| | Receptors, Transferrin | 1 | 2022 | 16 | 0.190 |
Why?
| | Ikaros Transcription Factor | 1 | 2022 | 5 | 0.190 |
Why?
| | Amino Acid Sequence | 10 | 2013 | 576 | 0.190 |
Why?
| | Protein Kinase C | 1 | 2002 | 72 | 0.190 |
Why?
| | Nuclear Proteins | 3 | 2009 | 247 | 0.190 |
Why?
| | Translocation, Genetic | 2 | 2021 | 266 | 0.180 |
Why?
| | Molecular Sequence Data | 10 | 2013 | 778 | 0.180 |
Why?
| | Isoenzymes | 1 | 2002 | 171 | 0.180 |
Why?
| | Virus Replication | 2 | 2013 | 147 | 0.180 |
Why?
| | Phosphofructokinase-1, Type C | 1 | 2021 | 3 | 0.180 |
Why?
| | Osteoclasts | 2 | 2022 | 423 | 0.180 |
Why?
| | YY1 Transcription Factor | 1 | 2021 | 7 | 0.180 |
Why?
| | Iron | 1 | 2022 | 123 | 0.180 |
Why?
| | Polycomb-Group Proteins | 1 | 2021 | 8 | 0.180 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2022 | 132 | 0.170 |
Why?
| | Predictive Value of Tests | 2 | 2025 | 938 | 0.160 |
Why?
| | Antigens, CD | 2 | 2019 | 213 | 0.160 |
Why?
| | Kidney | 1 | 2025 | 716 | 0.160 |
Why?
| | Vanadates | 1 | 2020 | 8 | 0.160 |
Why?
| | Phosphotyrosine | 1 | 2020 | 6 | 0.160 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 62 | 0.160 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2020 | 65 | 0.160 |
Why?
| | Neoplasms, Experimental | 1 | 2020 | 111 | 0.160 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 86 | 0.160 |
Why?
| | Prognosis | 3 | 2025 | 2100 | 0.160 |
Why?
| | Bone Resorption | 1 | 2022 | 300 | 0.160 |
Why?
| | Glomerulonephritis | 1 | 2019 | 16 | 0.160 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2019 | 47 | 0.150 |
Why?
| | Disease Models, Animal | 4 | 2025 | 1483 | 0.150 |
Why?
| | Protein Kinases | 1 | 2019 | 73 | 0.150 |
Why?
| | Ruminococcus | 1 | 2019 | 7 | 0.150 |
Why?
| | Integrin alpha Chains | 1 | 2019 | 9 | 0.150 |
Why?
| | Starch | 1 | 2019 | 12 | 0.150 |
Why?
| | Arsenic | 1 | 2019 | 22 | 0.150 |
Why?
| | Virulence Factors | 1 | 2019 | 78 | 0.150 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2021 | 202 | 0.150 |
Why?
| | Mice, Inbred C57BL | 6 | 2025 | 1888 | 0.150 |
Why?
| | Cecum | 1 | 2019 | 56 | 0.150 |
Why?
| | Cell Cycle Checkpoints | 1 | 2019 | 32 | 0.150 |
Why?
| | Melanoma, Experimental | 1 | 2019 | 34 | 0.150 |
Why?
| | Gene Expression Regulation, Bacterial | 4 | 2019 | 176 | 0.150 |
Why?
| | Methylation | 3 | 2025 | 124 | 0.150 |
Why?
| | Multiple Myeloma | 3 | 2019 | 3013 | 0.150 |
Why?
| | Cadherins | 1 | 2019 | 61 | 0.150 |
Why?
| | Replication Protein C | 2 | 2015 | 5 | 0.140 |
Why?
| | Antineoplastic Agents | 3 | 2022 | 1216 | 0.140 |
Why?
| | Peptide Hydrolases | 1 | 2018 | 62 | 0.140 |
Why?
| | Transcriptional Activation | 3 | 2025 | 127 | 0.140 |
Why?
| | Osteomyelitis | 1 | 2019 | 125 | 0.140 |
Why?
| | Thymus Gland | 1 | 2018 | 40 | 0.140 |
Why?
| | Parathyroidectomy | 1 | 2018 | 46 | 0.140 |
Why?
| | Thyroidectomy | 1 | 2018 | 61 | 0.140 |
Why?
| | Mutation | 5 | 2019 | 1331 | 0.130 |
Why?
| | Kidney Diseases | 1 | 2019 | 230 | 0.130 |
Why?
| | CTLA-4 Antigen | 1 | 2017 | 32 | 0.130 |
Why?
| | Histone Code | 1 | 2017 | 32 | 0.130 |
Why?
| | Parathyroid Hormone | 1 | 2018 | 143 | 0.130 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2017 | 46 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-maf | 1 | 2016 | 19 | 0.130 |
Why?
| | Multienzyme Complexes | 2 | 2015 | 43 | 0.130 |
Why?
| | Immunoglobulin G | 3 | 2023 | 193 | 0.120 |
Why?
| | Host-Pathogen Interactions | 2 | 2016 | 130 | 0.120 |
Why?
| | Mice, Knockout | 3 | 2025 | 903 | 0.120 |
Why?
| | DNA-Directed DNA Polymerase | 2 | 2015 | 89 | 0.120 |
Why?
| | Proteasome Inhibitors | 1 | 2016 | 101 | 0.120 |
Why?
| | Viral Load | 1 | 2016 | 81 | 0.120 |
Why?
| | Immunity, Innate | 1 | 2016 | 109 | 0.120 |
Why?
| | Human papillomavirus 16 | 1 | 2016 | 44 | 0.120 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 198 | 0.120 |
Why?
| | S Phase Cell Cycle Checkpoints | 1 | 2015 | 2 | 0.120 |
Why?
| | Papio | 2 | 2025 | 25 | 0.120 |
Why?
| | DNA Polymerase II | 1 | 2015 | 9 | 0.120 |
Why?
| | HeLa Cells | 3 | 2025 | 243 | 0.120 |
Why?
| | Cell Line, Tumor | 4 | 2021 | 1429 | 0.120 |
Why?
| | Cell Line | 4 | 2023 | 1020 | 0.120 |
Why?
| | Coculture Techniques | 1 | 2015 | 142 | 0.120 |
Why?
| | Cell Communication | 1 | 2015 | 74 | 0.120 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2004 | 48 | 0.110 |
Why?
| | Viral Proteins | 2 | 2013 | 164 | 0.110 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2022 | 202 | 0.110 |
Why?
| | Bone Marrow Cells | 1 | 2015 | 188 | 0.110 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2006 | 137 | 0.110 |
Why?
| | Enhancer Elements, Genetic | 2 | 2021 | 60 | 0.110 |
Why?
| | Chromatography, Liquid | 5 | 2020 | 245 | 0.110 |
Why?
| | Models, Biological | 3 | 2013 | 735 | 0.110 |
Why?
| | Prealbumin | 1 | 2014 | 22 | 0.110 |
Why?
| | Papillomavirus Infections | 1 | 2016 | 170 | 0.100 |
Why?
| | Gene Expression Profiling | 4 | 2023 | 1099 | 0.100 |
Why?
| | Amyloidosis | 1 | 2014 | 85 | 0.100 |
Why?
| | Chromosomes | 1 | 2013 | 29 | 0.100 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2016 | 299 | 0.100 |
Why?
| | Myocardium | 3 | 2006 | 471 | 0.100 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2012 | 30 | 0.100 |
Why?
| | Cardiomyopathies | 1 | 2014 | 117 | 0.100 |
Why?
| | Lung Neoplasms | 1 | 2019 | 643 | 0.100 |
Why?
| | Female | 11 | 2025 | 28277 | 0.090 |
Why?
| | Tumor Microenvironment | 3 | 2020 | 257 | 0.090 |
Why?
| | Receptors, Phospholipase A2 | 2 | 2023 | 14 | 0.090 |
Why?
| | Acetylation | 2 | 2021 | 96 | 0.090 |
Why?
| | Autoantibodies | 2 | 2023 | 118 | 0.090 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2010 | 11 | 0.080 |
Why?
| | Sumoylation | 1 | 2010 | 21 | 0.080 |
Why?
| | Replication Origin | 2 | 2025 | 11 | 0.080 |
Why?
| | Mice, Inbred BALB C | 2 | 2021 | 304 | 0.080 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2013 | 333 | 0.080 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2009 | 18 | 0.080 |
Why?
| | Chromatography, Affinity | 1 | 2009 | 38 | 0.080 |
Why?
| | 14-3-3 Proteins | 1 | 2009 | 18 | 0.080 |
Why?
| | Cytoskeleton | 3 | 2022 | 38 | 0.080 |
Why?
| | DNA Polymerase I | 1 | 2009 | 7 | 0.080 |
Why?
| | Histone Acetyltransferases | 1 | 2009 | 25 | 0.080 |
Why?
| | Maturation-Promoting Factor | 1 | 2009 | 1 | 0.080 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2009 | 9 | 0.080 |
Why?
| | Genes, Bacterial | 2 | 2006 | 51 | 0.080 |
Why?
| | Oogenesis | 1 | 2009 | 19 | 0.080 |
Why?
| | Cell Movement | 1 | 2010 | 271 | 0.080 |
Why?
| | Male | 9 | 2025 | 26874 | 0.080 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 3 | 2008 | 95 | 0.080 |
Why?
| | Xenopus | 1 | 2009 | 41 | 0.080 |
Why?
| | Disease Progression | 2 | 2025 | 870 | 0.080 |
Why?
| | Albuminuria | 1 | 2009 | 47 | 0.080 |
Why?
| | Epigenesis, Genetic | 2 | 2023 | 396 | 0.070 |
Why?
| | Virulence | 2 | 2019 | 160 | 0.070 |
Why?
| | Oocytes | 1 | 2009 | 95 | 0.070 |
Why?
| | Receptors, Cell Surface | 1 | 2009 | 111 | 0.070 |
Why?
| | Fungal Proteins | 1 | 2009 | 114 | 0.070 |
Why?
| | Cell Proliferation | 3 | 2021 | 1013 | 0.070 |
Why?
| | Actomyosin | 1 | 2008 | 1 | 0.070 |
Why?
| | Cytokinesis | 1 | 2008 | 4 | 0.070 |
Why?
| | Myelin Proteolipid Protein | 1 | 2008 | 21 | 0.070 |
Why?
| | Introns | 1 | 2008 | 53 | 0.070 |
Why?
| | Cytoskeletal Proteins | 1 | 2008 | 47 | 0.070 |
Why?
| | Biofilms | 2 | 2019 | 183 | 0.070 |
Why?
| | Fluorenes | 1 | 2007 | 11 | 0.070 |
Why?
| | Amino Acid Motifs | 2 | 2020 | 59 | 0.070 |
Why?
| | Cell Membrane | 1 | 2008 | 238 | 0.070 |
Why?
| | Pyrenes | 1 | 2006 | 4 | 0.060 |
Why?
| | Genome | 2 | 2023 | 61 | 0.060 |
Why?
| | Environmental Pollutants | 1 | 2008 | 104 | 0.060 |
Why?
| | Phosphorylation | 3 | 2016 | 536 | 0.060 |
Why?
| | Systems Biology | 1 | 2006 | 33 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2009 | 217 | 0.060 |
Why?
| | Dioxygenases | 1 | 2006 | 5 | 0.060 |
Why?
| | DNA, Fungal | 1 | 2006 | 43 | 0.060 |
Why?
| | Phosphopeptides | 2 | 2020 | 5 | 0.060 |
Why?
| | Valproic Acid | 1 | 2006 | 35 | 0.060 |
Why?
| | Complement Activation | 1 | 2025 | 27 | 0.060 |
Why?
| | Peptide Mapping | 2 | 2002 | 25 | 0.060 |
Why?
| | Papio anubis | 1 | 2025 | 5 | 0.060 |
Why?
| | Origin Recognition Complex | 1 | 2025 | 6 | 0.060 |
Why?
| | Organelles | 1 | 2005 | 11 | 0.060 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2002 | 68 | 0.060 |
Why?
| | Blood Proteins | 1 | 2005 | 84 | 0.060 |
Why?
| | Cardiovascular System | 1 | 2005 | 55 | 0.060 |
Why?
| | Mycobacterium smegmatis | 1 | 2004 | 3 | 0.060 |
Why?
| | Glucosyltransferases | 1 | 2004 | 6 | 0.060 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2019 | 51 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2025 | 113 | 0.060 |
Why?
| | Transcription, Genetic | 2 | 2005 | 375 | 0.060 |
Why?
| | Neutrophils | 1 | 2025 | 148 | 0.050 |
Why?
| | Ions | 2 | 2020 | 31 | 0.050 |
Why?
| | Binding Sites | 3 | 2013 | 379 | 0.050 |
Why?
| | Anticonvulsants | 1 | 2006 | 136 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2017 | 318 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2023 | 10 | 0.050 |
Why?
| | S-Adenosylmethionine | 1 | 2024 | 62 | 0.050 |
Why?
| | Protein Structure, Tertiary | 3 | 2013 | 260 | 0.050 |
Why?
| | Homocysteine | 1 | 2024 | 127 | 0.050 |
Why?
| | Biodegradation, Environmental | 3 | 2008 | 8 | 0.050 |
Why?
| | Histone Deacetylases | 1 | 2023 | 50 | 0.050 |
Why?
| | Cisplatin | 1 | 2025 | 282 | 0.050 |
Why?
| | Antigen-Antibody Complex | 1 | 2023 | 35 | 0.050 |
Why?
| | Cytokines | 2 | 2016 | 622 | 0.050 |
Why?
| | Animals, Newborn | 1 | 2023 | 355 | 0.050 |
Why?
| | Protein Kinase C-epsilon | 1 | 2002 | 5 | 0.050 |
Why?
| | Calcium | 2 | 2018 | 396 | 0.050 |
Why?
| | Apoptosis | 2 | 2019 | 1120 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 3 | 2007 | 69 | 0.050 |
Why?
| | Time Factors | 2 | 2025 | 2987 | 0.050 |
Why?
| | Cardiac Surgical Procedures | 1 | 2025 | 329 | 0.040 |
Why?
| | Glomerular Basement Membrane | 1 | 2021 | 9 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2025 | 1045 | 0.040 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2021 | 29 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2021 | 100 | 0.040 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 26 | 0.040 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2021 | 31 | 0.040 |
Why?
| | Proteoglycans | 1 | 2021 | 86 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 178 | 0.040 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2020 | 10 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 70 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2002 | 566 | 0.040 |
Why?
| | Thrombospondins | 1 | 2020 | 10 | 0.040 |
Why?
| | Genome, Human | 1 | 2021 | 121 | 0.040 |
Why?
| | Autoantigens | 1 | 2020 | 47 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2023 | 344 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2020 | 59 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2021 | 88 | 0.040 |
Why?
| | Jurkat Cells | 1 | 2020 | 28 | 0.040 |
Why?
| | Workflow | 1 | 2020 | 51 | 0.040 |
Why?
| | Protein Subunits | 2 | 2013 | 79 | 0.040 |
Why?
| | Protein Biosynthesis | 1 | 2002 | 267 | 0.040 |
Why?
| | Liver | 1 | 2006 | 1150 | 0.040 |
Why?
| | Heat-Shock Response | 1 | 2020 | 29 | 0.040 |
Why?
| | Peptides | 3 | 2006 | 239 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2021 | 187 | 0.040 |
Why?
| | Databases, Genetic | 1 | 2020 | 82 | 0.040 |
Why?
| | Kidney Glomerulus | 1 | 2019 | 41 | 0.040 |
Why?
| | Middle Aged | 3 | 2025 | 13133 | 0.040 |
Why?
| | Arsenate Reductases | 1 | 2019 | 3 | 0.040 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 10 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2021 | 180 | 0.040 |
Why?
| | Aged | 2 | 2025 | 10242 | 0.040 |
Why?
| | Membrane Transport Proteins | 1 | 2019 | 46 | 0.040 |
Why?
| | Sequence Alignment | 2 | 2009 | 121 | 0.040 |
Why?
| | Mitochondria | 1 | 2022 | 420 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2019 | 441 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2021 | 667 | 0.040 |
Why?
| | DNA Transposable Elements | 2 | 2008 | 107 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 140 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2019 | 150 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 82 | 0.030 |
Why?
| | Gene Order | 2 | 2007 | 13 | 0.030 |
Why?
| | Lamins | 1 | 2016 | 5 | 0.030 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2016 | 18 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2019 | 465 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2016 | 30 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2017 | 56 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 2 | 2007 | 89 | 0.030 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2016 | 76 | 0.030 |
Why?
| | Caspases | 1 | 2016 | 101 | 0.030 |
Why?
| | Vaccines, Subunit | 1 | 2016 | 15 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2016 | 269 | 0.030 |
Why?
| | Phylogeny | 2 | 2008 | 229 | 0.030 |
Why?
| | Molecular Structure | 2 | 2007 | 317 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 81 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 122 | 0.030 |
Why?
| | Immunophenotyping | 1 | 2015 | 115 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 2006 | 181 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 1558 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2004 | 178 | 0.030 |
Why?
| | Kinetics | 2 | 2006 | 613 | 0.030 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2006 | 64 | 0.030 |
Why?
| | Heterozygote | 1 | 2014 | 89 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2006 | 490 | 0.030 |
Why?
| | Cell Survival | 1 | 2015 | 598 | 0.030 |
Why?
| | Cyclin D | 1 | 2013 | 18 | 0.030 |
Why?
| | 3T3 Cells | 1 | 2013 | 57 | 0.030 |
Why?
| | Vaccination | 1 | 2016 | 294 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2013 | 76 | 0.030 |
Why?
| | High Mobility Group Proteins | 1 | 2013 | 2 | 0.030 |
Why?
| | Histone Chaperones | 1 | 2013 | 2 | 0.030 |
Why?
| | G1 Phase | 1 | 2013 | 13 | 0.030 |
Why?
| | Herpesviridae Infections | 1 | 2013 | 57 | 0.030 |
Why?
| | Transcriptional Elongation Factors | 1 | 2013 | 17 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2016 | 1134 | 0.020 |
Why?
| | Glucose | 2 | 2006 | 356 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 128 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 977 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2025 | 6694 | 0.020 |
Why?
| | Rats | 1 | 2019 | 3228 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 1365 | 0.020 |
Why?
| | Proteins | 2 | 2005 | 353 | 0.020 |
Why?
| | Protein Inhibitors of Activated STAT | 1 | 2010 | 2 | 0.020 |
Why?
| | Hepatocyte Growth Factor | 1 | 2010 | 11 | 0.020 |
Why?
| | COS Cells | 1 | 2010 | 76 | 0.020 |
Why?
| | Dogs | 1 | 2010 | 183 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2010 | 76 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2009 | 24 | 0.020 |
Why?
| | Protein Stability | 1 | 2009 | 45 | 0.020 |
Why?
| | Inositol 1,4,5-Trisphosphate | 1 | 2009 | 10 | 0.020 |
Why?
| | Formaldehyde | 1 | 2009 | 51 | 0.020 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2009 | 9 | 0.020 |
Why?
| | Phosphotransferases | 1 | 2009 | 17 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2009 | 57 | 0.020 |
Why?
| | Cattle | 1 | 2009 | 197 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2009 | 126 | 0.020 |
Why?
| | Diabetic Nephropathies | 1 | 2009 | 61 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 316 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2008 | 24 | 0.020 |
Why?
| | Adipates | 1 | 2008 | 1 | 0.020 |
Why?
| | Citric Acid Cycle | 1 | 2008 | 16 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 236 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2008 | 59 | 0.020 |
Why?
| | Mitosis | 1 | 2008 | 87 | 0.020 |
Why?
| | Protein Conformation | 1 | 2008 | 178 | 0.020 |
Why?
| | Acetyl Coenzyme A | 1 | 2007 | 5 | 0.020 |
Why?
| | Acyl Coenzyme A | 1 | 2007 | 8 | 0.020 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2007 | 32 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2008 | 177 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2010 | 1583 | 0.020 |
Why?
| | Multigene Family | 1 | 2006 | 49 | 0.020 |
Why?
| | Models, Molecular | 1 | 2008 | 356 | 0.020 |
Why?
| | Mice, Inbred ICR | 1 | 2006 | 25 | 0.020 |
Why?
| | Blood Pressure | 1 | 2009 | 525 | 0.020 |
Why?
| | Muscle Cells | 1 | 2006 | 20 | 0.020 |
Why?
| | S Phase | 1 | 2006 | 20 | 0.020 |
Why?
| | Young Adult | 1 | 2016 | 4346 | 0.020 |
Why?
| | DNA | 1 | 2009 | 544 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2006 | 59 | 0.020 |
Why?
| | Molecular Weight | 1 | 2006 | 78 | 0.020 |
Why?
| | Soil Microbiology | 1 | 2006 | 18 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2006 | 167 | 0.010 |
Why?
| | Databases, Protein | 1 | 2005 | 29 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2005 | 49 | 0.010 |
Why?
| | Genetic Markers | 1 | 2005 | 108 | 0.010 |
Why?
| | Isoelectric Focusing | 1 | 2004 | 8 | 0.010 |
Why?
| | Ubiquitin | 1 | 2005 | 70 | 0.010 |
Why?
| | Ammonium Sulfate | 1 | 2004 | 1 | 0.010 |
Why?
| | Cellulose | 1 | 2004 | 4 | 0.010 |
Why?
| | Maltose | 1 | 2004 | 3 | 0.010 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2004 | 4 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 2004 | 15 | 0.010 |
Why?
| | Proton-Translocating ATPases | 1 | 2004 | 10 | 0.010 |
Why?
| | Chromatography | 1 | 2004 | 11 | 0.010 |
Why?
| | Trehalose | 1 | 2004 | 6 | 0.010 |
Why?
| | Disaccharides | 1 | 2004 | 10 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 2004 | 40 | 0.010 |
Why?
| | Base Sequence | 1 | 2006 | 632 | 0.010 |
Why?
| | Databases as Topic | 1 | 2004 | 38 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2004 | 54 | 0.010 |
Why?
| | Catalysis | 1 | 2004 | 88 | 0.010 |
Why?
| | Carbohydrates | 1 | 2004 | 41 | 0.010 |
Why?
| | Cytosol | 1 | 2004 | 82 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2006 | 412 | 0.010 |
Why?
| | Substrate Specificity | 1 | 2004 | 197 | 0.010 |
Why?
| | Myocardial Ischemia | 1 | 2005 | 130 | 0.010 |
Why?
| | Escherichia coli | 1 | 2004 | 182 | 0.010 |
Why?
| | Gene Expression | 1 | 2006 | 618 | 0.010 |
Why?
| | Pilot Projects | 1 | 2005 | 725 | 0.010 |
Why?
| | Trypsin | 1 | 2002 | 12 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 378 | 0.010 |
Why?
| | Hydrolysis | 1 | 2002 | 66 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2002 | 214 | 0.010 |
Why?
| | Myocardial Infarction | 1 | 2005 | 449 | 0.010 |
Why?
| | Inflammation | 1 | 2005 | 649 | 0.010 |
Why?
| | Adult | 1 | 2016 | 14205 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2005 | 493 | 0.010 |
Why?
| | Pregnancy | 1 | 2006 | 2642 | 0.010 |
Why?
|
|
Edmondson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|